GPT and metabolic dysfunction-associated steatotic liver disease: Figure 2 shows the dose–response relationships between the above factors and NAFLD risk by RCS analysis after adjusting age, sex, BMI, SBP, DBP, ALT, AST, GGT, TP, TBIL, Cr, UA, and glucose.